Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

Patient adherence to tuberculosis treatment may be improved by using mobile text messaging and electronic pillboxes, according to a study published in the journal PLOS Medicine. The randomized ...

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...

Analysis of finger sweat detected isoniazid in adults with tuberculosis (TB) for ≤ 6 hours after administration, based on data from a new pilot study. Risk factors for TB treatment failure include ...

Patients with tuberculosis who used a digital medication reminder monitor had better health-related quality of life (HRQOL) and lower catastrophic costs compared with patients who used a standard ...

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium ...

An individual within the Aegis Living retirement community in Issaquah was diagnosed with active tuberculosis on Monday.

This image depicts a large group of orange-colored, rod shaped, Mycobacterium tuberculosis bacteria, which cause tuberculosis. An active TB case was reported Monday in Tacoma by the local health ...